Paper34673293
Antimicrobial susceptibility of Gram-negative bacteria from intensive care unit and non-intensive care unit patients from United States hospitals (2018-2020).
Sader HS and 4 others. Diagn Microbiol Infect Dis, 2022. Cited by 38 papers, by iCite.
Cite this record
ConductScience Library. Antimicrobial susceptibility of Gram-negative bacteria from intensive care unit and non-intensive care unit patients from United States hospitals (2018-2020). Papers, record 34673293. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34673293
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Antimicrobial susceptibility of Gram-negative bacteria from intensive care unit and non-intensive care unit patients from United States hospitals (2018-2020).
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anti-Bacterial Agents | Major topic |
| Gram-Negative Bacteria | Major topic |
| Drug Resistance, Bacterial | |
| Gram-Negative Bacterial Infections | |
| Hospitals | |
| Humans | |
| Intensive Care Units | |
| Microbial Sensitivity Tests | |
| United States |
Source PubMed
Cited by30
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 38 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42859498 | Genomic epidemiology of multidrug-resistant Klebsiella pneumoniae reveals lineage-specific resistance patterns with limited virulence determinants. | AIMS Microbiol | 2026 | https://conductscience.org/library/papers/42859498 | PubMed |
| 42534385 | Phenotypic and Genotypic Characterization of Carbapenem-Resistant Acinetobacter baumannii Clinical Isolates: Co-Existence of blaOXA-23 and blaNDM-1 in a Vietnamese Tertiary Hospital. | Int J Microbiol | 2026 | https://conductscience.org/library/papers/42534385 | PubMed |
| 41959558 | Development and validation of an interpretable machine learning-based model for predicting carbapenem-resistant Acinetobacter baumannii infection in postoperative ICU patients: a retrospective cohort study. | Front Cell Infect Microbiol | 2026 | https://conductscience.org/library/papers/41959558 | PubMed |
| 41278469 | CRAB-RSS: development and validation of a single-center risk stratification model for carbapenem-resistant Acinetobacter baumannii in ICU patients based on mechanical ventilation, carbapenem exposure, and hospitalization duration. | Front Cell Infect Microbiol | 2025 | https://conductscience.org/library/papers/41278469 | PubMed |
| 41156790 | Trends in the Antimicrobial Resistance Pattern of Bacterial Gram-Negative Pathogens in Elderly Patients Admitted to the Intensive Care Unit. | Microorganisms | 2025 | https://conductscience.org/library/papers/41156790 | PubMed |
| 41065368 | Current and future options for the treatment of serious infections due to carbapenem-resistant Pseudomonas aeruginosa. | Clin Microbiol Rev | 2025 | https://conductscience.org/library/papers/41065368 | PubMed |
| 40655052 | Multidrug Resistance Gram-negative Bacteria in Intensive Care Unit of Tertiary Care Hospital: A Descriptive Cross-sectional Study. | JNMA J Nepal Med Assoc | 2024 | https://conductscience.org/library/papers/40655052 | PubMed |
| 40558128 | Efficacy of Endolysin LysAB1245 Combined with Colistin as Adjunctive Therapy Against Colistin-Resistant Gram-Negative Bacteria. | Antibiotics (Basel) | 2025 | https://conductscience.org/library/papers/40558128 | PubMed |
| 40001421 | Difficult-to-Treat Pseudomonas aeruginosa Infections in Critically Ill Patients: A Comprehensive Review and Treatment Proposal. | Antibiotics (Basel) | 2025 | https://conductscience.org/library/papers/40001421 | PubMed |
| 39680587 | Geographical mapping and temporal trends of Acinetobacter baumannii carbapenem resistance: A comprehensive meta-analysis. | PLoS One | 2024 | https://conductscience.org/library/papers/39680587 | PubMed |
| 39617865 | Trends in Bacterial Distribution and Antimicrobial Resistance in Intensive Care Units of Hubei Province, China: A Four-year Surveillance Study (2020-2023). | Curr Med Sci | 2024 | https://conductscience.org/library/papers/39617865 | PubMed |
| 39051678 | Bayesian estimation of the prevalence of antimicrobial resistance: a mathematical modelling study. | J Antimicrob Chemother | 2024 | https://conductscience.org/library/papers/39051678 | PubMed |
| 39048999 | Prevalence of rectal carbapenem resistant Enterobacterales carriage among patients attending healthcare facilities in Ibadan, Nigeria: a descriptive study. | BMC Infect Dis | 2024 | https://conductscience.org/library/papers/39048999 | PubMed |
| 38254025 | An analysis of differences in Carbapenem-resistant Enterobacterales in different regions: a multicenter cross-sectional study. | BMC Infect Dis | 2024 | https://conductscience.org/library/papers/38254025 | PubMed |
| 38222461 | Activity of ceftolozane/tazobactam, imipenem/relebactam and ceftazidime/avibactam against clinical Gram-negative isolates-SMART United States 2019-21. | JAC Antimicrob Resist | 2024 | https://conductscience.org/library/papers/38222461 | PubMed |
| 38098829 | Insights into the epidemiology, risk factors, and clinical outcomes of carbapenem-resistant Acinetobacter baumannii infections in critically ill children. | Front Public Health | 2023 | https://conductscience.org/library/papers/38098829 | PubMed |
| 37824582 | The PitA protein contributes to colistin susceptibility in Pseudomonas aeruginosa. | PLoS One | 2023 | https://conductscience.org/library/papers/37824582 | PubMed |
| 37533805 | Antimicrobial stewardship in the intensive care unit. | J Intensive Med | 2023 | https://conductscience.org/library/papers/37533805 | PubMed |
| 37215420 | Burden of severe infections due to carbapenem-resistant pathogens in intensive care unit. | World J Clin Cases | 2023 | https://conductscience.org/library/papers/37215420 | PubMed |
| 37192202 | Ceftazidime resistance in Pseudomonas aeruginosa is multigenic and complex. | PLoS One | 2023 | https://conductscience.org/library/papers/37192202 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/34673293
GET https://conductscience.org/api/papers/v1/34673293/cited_by?page=2